Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
Oct 3 BBIO BridgeBio granted Perform rating at Oppenheimer on market challenges
Oct 3 BBIO BridgeBio to Present Outcomes Data Through 42 Months from the Open-Label Extension of ATTRibute-CM, the Phase 3 Study of Acoramidis for Treatment of ATTR-CM, at 2024 AHA Scientific Sessions
Oct 2 CYTK Cytokinetics to Host Investor & Analyst Day on October 16, 2024
Oct 1 BBIO 5 FDA decisions to watch in the fourth quarter
Oct 1 CYTK Is Cytokinetics Inc. (CYTK) Positioned for Success with Its Innovative Muscle Modulators?
Sep 30 CLDX Celldex started by Goldman Sachs at neutral, lack of catalysts cited
Sep 30 BBIO BridgeBio Pharma's Lead Candidate Cuts Mortality, Related Hospitalizations In Patients With Certain Type Of Heart Disease
Sep 30 CYTK Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
Sep 30 BBIO BridgeBio Completes Enrollment of FORTIFY, Phase 3 Registrational Study of BBP-418 in Limb-girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9)
Sep 27 BBIO BridgeBio Shares Recurrent Event Analysis of ATTRibute-CM, Demonstrating a 42% Reduction by Acoramidis on the Composite Endpoint of All-Cause Mortality and Recurrent Cardiovascular-related Hospitalization Events
Sep 27 FBIO Fortress Biotech files to sell 6.19M shares of common stock for holders
Sep 27 CYTK Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
Sep 26 VNDA Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
Sep 26 CLDX CLDX Stock Down Despite Upbeat Long-Term Data From Urticaria Study
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags